Condition: Crohn Disease · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| AZ Gastro Care | Chandler, Arizona, United States | Recruiting |
| Research Solutions of Arizona | Litchfield Park, Arizona, United States | Recruiting |
| Mayo Clinic | Scottsdale, Arizona, United States | Recruiting |
| Clinnova Research | Anaheim, California, United States | Recruiting |
| Alliance Research Institute, LLC - Canoga Park | Canoga Park, California, United States | Recruiting |
| Southern California Research Center | Coronado, California, United States | Recruiting |
| Om Research, LLC 1 | Lancaster, California, United States | Recruiting |
| TLC Clinical Research Inc | Los Angeles, California, United States | Recruiting |
| GastroIntestinal Bioscience | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital | Newport Beach, California, United States | Recruiting |
| Om Research, LLC 2 | Oxnard, California, United States | Recruiting |
| Clinical Applications Laboratories, Inc | San Diego, California, United States | Recruiting |
+ 355 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07196722